This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Gilead Sciences.
Costs were reported in 2019 Iraqi Dinar or US dollars, and both costs and benefits were discounted at 3.5% per year.
Reference
Asker B, et al. Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment Internet Document : 16 Aug 2021. Available from: URL: https://doi.org/10.1007/s40273-021-01064-z
Rights and permissions
About this article
Cite this article
Simplified one-stop HCV testing and confirmatory diagnosis cost effective in Iraq. PharmacoEcon Outcomes News 886, 23 (2021). https://doi.org/10.1007/s40274-021-08001-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08001-4